Kids & teens (for parents) · Washington
Studies for children and teens in Washington
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
37 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Seattle, WA + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 4
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Bausch Health Americas, Inc.
- Location
- Spokane, WA + 13 other US sites
- Eligibility basics
- Ages 9–11
- RecruitingPhase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
AbbVie
- Location
- Everett, WA + 30 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 1/Phase 2
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Solid Biosciences Inc.
- Location
- Seattle, WA + 11 other US sites
- Eligibility basics
- Ages 0 mo–17 · Men only
- RecruitingPhase 4
Two Dose Levels of Privigen in Pediatric CIDP
CSL Behring
- Location
- Seattle, WA + 2 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical
- Location
- Seattle, WA + 30 other US sites
- Eligibility basics
- Ages 3–11
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- Seattle, WA + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Merck Sharp & Dohme LLC
- Location
- Seattle, WA + 8 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- Seattle, WA + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Lynnwood, WA + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingHealthy volunteersPhase 2/Phase 3
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
University of Washington
- Location
- Tacoma, WA
- Eligibility basics
- Ages 0 mo–2
- RecruitingHealthy volunteers
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
Seattle Children's Hospital
- Location
- Seattle, WA + 1 other US site
- Eligibility basics
- Ages 11–17
- RecruitingHealthy volunteers
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Petter Bjornstad
- Location
- Seattle, WA + 1 other US site
- Eligibility basics
- Ages 8–14